May 5, 2021

SARS-CoV-2 Outbreak in Immune-Mediated Inflammatory Diseases: The Euro-COVIMID Multicentre Cross-Sectional Study

Category: Article Summary

Topic: Clinical Characteristics and Health Care Setting

Keywords (Tags): clinical characteristics, immunity

• In a study including 3,028 patients in Europe with immune-mediated inflammatory disease, symptomatic COVID-19 occurred in 4% (n=122) and anti-SARS-CoV-2 antibodies were detected in 5% (n=166) of patients between June and December 2020. Symptomatic COVID-19 was associated with higher concentrations of C-reactive protein (OR=1.2) and higher numbers of disease flares (OR=1.3). 

Saadoun et al. (Apr 2021). SARS-CoV-2 Outbreak in Immune-Mediated Inflammatory Diseases: The Euro-COVIMID Multicentre Cross-Sectional Study. The Lancet Rheumatology. https://doi.org/10.1016/S2665-9913(21)00112-0